Eglumegad
Eglumegad, also known as LY354740, is a research drug developed by Eli Lilly and Company, which is being investigated for its potential in the treatment of anxiety and drug addiction. It is a glutamate derived compound and its mode of action implies a novel mechanism.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD169 |
| CAS # | 176199-48-7 |
| Pricing | Customizable size, Inquiry |
| Synonym | Eglumetad; LY-354740; LY354740; LY 354740; Eglumegad |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C8H11NO4 |
| Exact Mass | 185.0688 |
| Molecular Weight | 185.179 |
| Elemental Analysis | C, 51.89; H, 5.99; N, 7.56; O, 34.56 |
| IUPAC/Chemical Name | (1S,2S,5R,6S)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid |
| InChi Key | VTAARTQTOOYTES-RGDLXGNYSA-N |
| InChi Code | InChI=1S/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1 |
| SMILES Code | O=C([C@@]1(N)[C@]2([H])[C@@H](C(O)=O)[C@]2([H])CC1)O |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Class-2 | Schizophrenia |
| Availability | 2 Weeks |